GeoVax Labs, Inc. announced its participation in a collaborative effort led by researchers at the University of California, San Francisco, to develop a combinational therapy aimed at inducing remission in HIV-positive individuals The studies will be conducted with funding from amfAR, The Foundation for AIDS Research..
November 14, 2019
· 5 min read